Annual EBIT
$25.60B$4.77B+22.92%
Summary
- Current Value
- As of today, JNJ annual EBIT is $25.60B, up +22.92% on
- Historical Performance
- JNJ annual EBIT is up +20.70% over the past 3 years, up +25.05% over the past 5 years
- All-Time High Comparison
- JNJ annual EBIT is currently at its all-time high
- 3-Year Low Comparison
- JNJ annual EBIT is +22.92% above its 3-year low of $20.82B reached on
- Sector Comparison
- JNJ annual EBIT is higher than 99.82% of companies in Healthcare sector
EBIT Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $25.60B | +22.9% | +20.7% | +25.1% | +52.2% | |
| Quarterly EBIT | $6.37B | -10.5% | +6.1% | -5.5% | +60.0% | |
| TTM EBIT | $25.69B | +8.1% | +12.4% | +6.3% | +55.3% | |
| Price | $252.20 | +30.5% | +65.6% | +53.9% | +302.6% | |
| PE Ratio | 38.26 | +105.2% | +31.6% | +56.2% | +150.4% | |
| Annual Revenue | $94.18B | +6.0% | +17.6% | +14.1% | +52.8% | |
| Annual EPS | $11.03 | +90.6% | +63.8% | +100.3% | +130.8% | |
| Annual EBITDA | $33.63B | +19.4% | +19.3% | +21.4% | +70.2% | |
| Annual Net Income | $26.80B | +90.6% | +63.7% | +82.2% | +101.0% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $25.60B | at high | |
| 5Y | $25.60B | at high | |
| All | $25.60B | at high |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $20.82B | +22.9% | |
| 5Y | $20.47B | N/A | +25.1% |
| All | $616.10M | +4054.5% |
EBIT History
FAQ
- What is the current annual EBIT of JNJ?
- As of today, JNJ annual EBIT is $25.60B
- What is 1-year change in JNJ annual EBIT?
- JNJ annual EBIT is up +22.92% year-over-year
- What is 3-year change in JNJ annual EBIT?
- JNJ annual EBIT is up +20.70% over the past 3 years
- How far is JNJ annual EBIT from its all-time high?
- JNJ annual EBIT is currently at its all-time high
- How does JNJ annual EBIT rank versus sector peers?
- JNJ annual EBIT is higher than 99.82% of companies in Healthcare sector
- When is JNJ next annual earnings release?
- The next annual earnings release for JNJ is on
EBIT Formula
Quarterly EBIT
$6.37B$1.00B-13.59%
Summary
- Current Value
- As of today, JNJ quarterly EBIT is $6.37B, down -13.59% on
- Historical Performance
- JNJ quarterly EBIT is down -10.50% year-over-year, up +6.10% over the past 3 years
- All-Time High Comparison
- JNJ quarterly EBIT is currently -13.59% below its historical high of $7.37B set on
- 3-Year Low Comparison
- JNJ quarterly EBIT is +81.03% above its 3-year low of $3.52B reached on
- Sector Comparison
- JNJ quarterly EBIT is higher than 99.81% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $6.37B | -13.6% | -10.5% | +6.1% | -5.5% | |
| Annual EBIT | $25.60B | – | +22.9% | +20.7% | +25.1% | |
| TTM EBIT | $25.69B | -2.8% | +8.1% | +12.4% | +6.3% | |
| Price | $252.20 | -0.3% | +30.5% | +65.6% | +53.9% | |
| PE Ratio | 38.26 | +30.4% | +105.2% | +31.6% | +56.2% | |
| Quarterly Revenue | $25.40B | +0.3% | +5.9% | +19.0% | +8.8% | |
| Quarterly EPS | $0.09 | -96.2% | -96.0% | -95.7% | -93.7% | |
| Quarterly EBITDA | - | – | – | – | – | |
| Quarterly Net Income | $210.00M | -96.2% | -95.9% | -95.1% | -94.3% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.37B | -13.6% | |
| 3Y | $7.37B | -13.6% | |
| 5Y | $7.37B | -13.6% | |
| All | $7.37B | -13.6% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.38B | +18.3% | |
| 3Y | $3.52B | +81.0% | |
| 5Y | $3.52B | +81.0% | |
| All | -$5.40B | +218.0% |
Quarterly EBIT History
FAQ
- What is the current quarterly EBIT of JNJ?
- As of today, JNJ quarterly EBIT is $6.37B
- What is JNJ quarterly EBIT most recent change?
- JNJ quarterly EBIT was down -13.59% on September 30, 2026
- What is 1-year change in JNJ quarterly EBIT?
- JNJ quarterly EBIT is down -10.50% year-over-year
- How far is JNJ quarterly EBIT from its all-time high?
- JNJ quarterly EBIT is currently -13.59% below its historical high of $7.37B set on June 30, 2026
- How does JNJ quarterly EBIT rank versus sector peers?
- JNJ quarterly EBIT is higher than 99.81% of companies in Healthcare sector
- When is JNJ next earnings release?
- The next earnings release for JNJ is on
EBIT Formula
TTM EBIT
$25.69B$747.00M-2.83%
Summary
- Current Value
- As of today, JNJ TTM EBIT is $25.69B, down -2.83% on
- Historical Performance
- JNJ TTM EBIT is up +8.08% year-over-year, up +12.44% over the past 3 years
- All-Time High Comparison
- JNJ TTM EBIT is currently -2.83% below its historical high of $26.43B set on
- 3-Year Low Comparison
- JNJ TTM EBIT is +22.94% above its 3-year low of $20.89B reached on
- Sector Comparison
- JNJ TTM EBIT is higher than 99.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $25.69B | -2.8% | +8.1% | +12.4% | +6.3% | |
| Annual EBIT | $25.60B | – | +22.9% | +20.7% | +25.1% | |
| Quarterly EBIT | $6.37B | -13.6% | -10.5% | +6.1% | -5.5% | |
| Price | $252.20 | -0.3% | +30.5% | +65.6% | +53.9% | |
| PE Ratio | 38.26 | +30.4% | +105.2% | +31.6% | +56.2% | |
| TTM Revenue | $99.35B | +1.4% | +7.8% | +18.7% | +8.7% | |
| TTM EPS | $6.59 | -23.6% | -36.4% | +25.8% | -1.5% | |
| TTM EBITDA | - | – | – | – | – | |
| TTM Net Income | $16.10B | -23.5% | -35.9% | +29.6% | -10.0% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $26.43B | -2.8% | |
| 3Y | $26.43B | -2.8% | |
| 5Y | $26.43B | -2.8% | |
| All | $26.43B | -2.8% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $23.76B | N/A | +8.1% |
| 3Y | $20.89B | +22.9% | |
| 5Y | $20.89B | +22.9% | |
| All | -$2.11B | +1319.0% |
TTM EBIT History
FAQ
- What is the current TTM EBIT of JNJ?
- As of today, JNJ TTM EBIT is $25.69B
- What is JNJ TTM EBIT most recent change?
- JNJ TTM EBIT was down -2.83% on September 30, 2026
- What is 1-year change in JNJ TTM EBIT?
- JNJ TTM EBIT is up +8.08% year-over-year
- How far is JNJ TTM EBIT from its all-time high?
- JNJ TTM EBIT is currently -2.83% below its historical high of $26.43B set on June 30, 2026
- How does JNJ TTM EBIT rank versus sector peers?
- JNJ TTM EBIT is higher than 99.91% of companies in Healthcare sector
- When is JNJ next earnings release?
- The next earnings release for JNJ is on
EBIT Formula
Data Sources & References
- JNJ Official Website www.jnj.com
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj
